品牌
代理商厂商性质
上海市所在地
Cell Line | Cell Line Species/Tissue | Nucleic Acid | Reagent | Transfection Type | Transfection Efficiency(%) |
---|---|---|---|---|---|
293T | Human Embryonic Kidney | DNA | DNAfectinTM 2100 Transfection Reagent | Transient | 100% |
Jurkat | Human T Lymphoma | DNA | DNAfectinTM 2100 Transfection Reagent | Transient | 25% |
SHEP | Human Neuroblastoma | DNA | DNAfectinTM 2100 Transfection Reagent | Transient | 90% |
BOSC23 | Human Kidney | DNA | DNAfectinTM 2100 Transfection Reagent | Transient | 90% |
HT1080 | Human Fibrosarcoma | DNA | DNAfectinTM 2100 Transfection Reagent | Transient | 80% |
C33A | Human Cervical Carcinoma | DNA | DNAfectinTM 2100 Transfection Reagent | Transient | 90% |
MRC5 | Human Primary Fibroblast | DNA | DNAfectinTM 2100 Transfection Reagent | Transient | 80% |
MDK-o | Dog Kidney Cells+o | DNA | DNAfectinTM 2100 Transfection Reagent | Transient | 80% |
B16 | Murine Melanoma | DNA | DNAfectinTM 2100 Transfection Reagent | Transient | 80% |
CB3 | Mouse Erytholeukemia | DNA | DNAfectinTM 2100 Transfection Reagent | Transient | 25% |
HuVEC | Human Ubilical Vein | DNA | DNAfectinTM 2100 Transfection Reagent | Transient | 20% |
HepG2 | Human Liver Carcinoma | DNA | DNAfectinTM 2100 Transfection Reagent | Transient | 40% |
MMRU | Human Melanoma | DNA | DNAfectinTM 2100 Transfection Reagent | Transient | 75% |
MMAN | Human Melanoma | DNA | DNAfectinTM 2100 Transfection Reagent | Transient | 80% |
MDA-MB-231 | Human Breast Carcinoma | DNA | DNAfectinTM 2100 Transfection Reagent | Transient | 85% |
HeLa | Human Cervical Carcinoma | DNA | DNAfectinTM 2100 Transfection Reagent | Transient | 80%-90% |
A2780 | Human Ovarian Carcinoma | DNA | DNAfectinTM 2100 Transfection Reagent | Transient | 70%-75% |
L6 | Rat Myoblast | DNA | DNAfectinTM 2100 Transfection Reagent | Transient | 60%-70% |
Rabbit-o | omerase-Rabbit Cells | DNA | DNAfectinTM 2100 Transfection Reagent | Transient | 50% |
USO2 (T-USO2) | Human Osteosarcoma (tet-inducible) | DNA | DNAfectinTM 2100 Transfection Reagent | Transient | 80%-90% |